← Back to Search

Radiopharmaceutical

99mTc-Sestamibi for Coronary Artery Disease

Phase 2
Waitlist Available
Led By Gary Heller, MD
Research Sponsored by Cell>Point LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1a through visit 3 approximately 3 to 20 days
Awards & highlights

Study Summary

This trial will compare two different radiolabeled agents used to test for coronary artery disease during a rest and stress cardiac test.

Eligible Conditions
  • Coronary Artery Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1a through visit 3 approximately 3 to 20 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1a through visit 3 approximately 3 to 20 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy: Characterization of the efficacy of 99mTCc-ECDG in the evaluation of Coronary Artery Disease
Secondary outcome measures
Safety: The number of participants with Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: 99mTc-EC-DG, DiagnosticExperimental Treatment1 Intervention
99mTc-EC-DG (25 ± 5 mCi, up to 250 µg EC-DG) will be administered by intravenous (IV) bolus injection. Other Name:Technetium-99m-labeled Ethylenedicysteine-Deoxyglucose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
99mTc-Sestamibi
2012
N/A
~120

Find a Location

Who is running the clinical trial?

Cell>Point LLCLead Sponsor
4 Previous Clinical Trials
182 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
2 Patients Enrolled for Coronary Artery Disease
Gary Heller, MDPrincipal InvestigatorConsultant
~14 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top